Prudomestin

Prudomestin

SCHEMBL30977124

COc1ccc(-c2oc3c(OC)c(O)cc(O)c3c(=O)c2O)cc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.65
PDE5A O76074 2/20 0.65
KDM1A O60341 1/20 0.65
PKMYT1 Q99640 1/20 0.65
MAOA P21397 2/20 0.64
CYP1A1 P04798 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP1B1 Q16678 1/20 0.64
FTO Q9C0B1 1/20 0.64
MAPT P10636 5/20 0.59
TUBB4A P04350 1/20 0.59
TUBB P07437 1/20 0.59
TUBA3C P0DPH7 1/20 0.59
PKM P14618 1/20 0.59
XDH P47989 1/20 0.59
TUBA1B P68363 1/20 0.59
TUBA4A P68366 1/20 0.59
TUBB4B P68371 1/20 0.59
TUBB3 Q13509 1/20 0.59
TUBB2A Q13885 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30095422 0.91 FBP1 (0.71) ABCB1PDE5AKDM1APKMYT1MAOA
SCHEMBL1608916 0.91 FBP1 (0.71) ABCB1PDE5AKDM1APKMYT1MAOA
Tambulin SCHEMBL29728591 0.90 ALDH1A1 (0.64) ABCB1PDE5AKDM1APKMYT1MAOA
Tambulin SCHEMBL4742083 0.90 ALDH1A1 (0.64) ABCB1PDE5AKDM1APKMYT1MAOA
SCHEMBL13552034 0.90 FBP1 (0.72) ABCB1PDE5AKDM1APKMYT1MAOA
SCHEMBL30434092 0.87 KDM4E (0.71) PDE5AMAPTXDHFBP1KDM4E
SCHEMBL1764438 0.85 ALDH1A1 (0.67) ABCB1PDE5AKDM1APKMYT1MAOA
Limocitrin SCHEMBL29411754 0.85 MEN1 (0.65) ABCB1CYP1A1CYP1A2CYP1B1MAPT
Limocitrin SCHEMBL3688642 0.85 MEN1 (0.65) ABCB1CYP1A1CYP1A2CYP1B1MAPT
SCHEMBL28187412 0.85 ABCG2 (0.67) ABCB1PDE5AKDM1APKMYT1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12507703-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-12-30 US disclosed
US-20250169516-A1 METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-05-29 US disclosed
US-12239142-B2 Methods, devices and compositions for preserving human milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2025-03-04 US disclosed
US-20240268402-A1 Methods, Devices and Compositions for Preserving Human Milk THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2024-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12507703-B2 Methods, devices and compositions for preserving human milk LPL, CEL, LPO ABCB1 4482/4885PDE5A 1486/4885KDM1A 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.